期刊文献+

尿苷类酰卤化过程中相关中间体的实验研究 被引量:4

An Experimental Study on Related Intermediates in Acylation and Halogenation of Uridines
下载PDF
导出
摘要 目的证明2,2′脱水衍生物是尿苷类化合物在乙腈(或乙酸乙酯)中与酰卤作用的中间体。方法用改进的方法合成出2,2′脱水尿苷衍生物,与尿苷类化合物和酰卤作用形成的中间体经TLC、熔点、MS、1HNMR等实验进行比较以确认中间体的归属。结果与结论证实了尿苷类酰化卤化过程中的中间体是2,2′脱水尿苷衍生物,这为以2,2′脱水5甲基尿苷为原料合成d4T提供了新的合成途径。 Objective: To prove that 2,2′-anhydrouridine is the intermediate of the reaction of uridine with acyl halide in acetonitrile (or ethyl acetate). Methods: 2,2′-anhydrauride derivative was synthesized using an improved method. Its characters including TLC, mp, MS and 1 HNMR were compared with those of the intermediate of the reaction of uridine with acyl halide, so that the structure of intermediate could be confirmed. Results and Conclusion: Comparison studies prove that the intermediate in acylation and halogention of uridines is 2,2′-anhydrouridine derivative. These results provide a new path to synthesize d4T from 2,2′-anhydro-5-methyluridine.
出处 《药学进展》 CAS 2005年第7期327-331,共5页 Progress in Pharmaceutical Sciences
关键词 尿苷 卤化 酰化 2 2’-脱水尿苷 中间体 Uridine Acylation Halogenation 2,2′-Anhydrouridine Intermediate
  • 相关文献

参考文献5

  • 1Marumoto R, Honjo M. One-step halogenation at the 2'position of uridine, and related reactions of cytidine and N4acetylcytidine[J]. Chem Pharm Bull, 1974, 22(1): 128-134.
  • 2Chen B-C, Quinlan S L, Reid J G, et al. A new thymine free synthesis of the anti-AIDS drug d4T via regio/stereo controlled β-elimination of bromoacetates [ J ]. Tetrahedron Lett, 1998,39(8): 729-732.
  • 3姚其正 吕刚.制备2′,3′-二脱氢-3′-脱氧胸苷的新方法[P].中国专利: CN1324800A.2001-06-01.
  • 4Freskos J N, Senaratna K P A. Synthesis of beta-thymidine [P]. US:4914233, 1990-04-03.
  • 5姚其正 张志祥.2,2′-脱水尿苷的制备方法[P].中国专利:XLO11137397.0.2001-12-18.

共引文献1

同被引文献39

  • 1徐颂,姚其正.抗艾滋病药物司他呋啶合成方法研究[J].药学进展,2005,29(5):203-212. 被引量:1
  • 2姜迅知,鞠玻.司他夫定的合成[J].中国医药工业杂志,2007,38(6):403-404. 被引量:1
  • 3曹萌萌,李玲,罗振福,黄耀东.2'-脱氧-5-氟尿苷的合成工艺改进[J].天津药学,2007,19(4):82-84. 被引量:2
  • 4Nair V.Antiviral isonucleosides:discovery,chemistry and chemical biology[M].//Chu C K.Recent Advances in Nucleosides:Chemistry and Chemotherapy.New York:Elservier Science B V,2002:149-166.
  • 5Chu C K,Ma L,Olgen S,et al.Synthesis and antiviral activity of oxaselenolane nucleosides[J].J Med Chem,2000,43(21):3906-3912.
  • 6Schott H,Ludwig P S,Immelmarm A,et al.Synthesis and in vitro anti-HIV activities of amphiphilic heterodinucleoside phosphate derivatives containing the 2',3'-dideoxynucleosides ddC,AZT and ddl[J].Eur J Med Chem.1999,34(4):343-352.
  • 7Pierra C,Imbach J L,De Clercq E,et al.Synthesis and antiviral evaluation of,beta-L-2',3'-dideoxy-5-chloro pyrimidine nucleosides and pronucleotides[J].Antiviral Res,2000,45(3):169-183.
  • 8Qiu X L,Xu X H,Qing F L.Recent advances in the synthesis of fluorinated nucleosides[J].Tetrahedron,2010,66(4):789-843.
  • 9Kumar V,Malhotra S V.Synthesis of nucleoside-based antiviral drugs in ionic liquids[J].Bioorg Med Chem Lett,2008,18(20):56405642.
  • 10Bertolini G,Castoldi P,Deleo M,et al.Process for preparing 2',3'-didehydro-2',3'-dideoxynucleosides and 2',3'-dideoxynucleosides via reductive elimination reaction:US,10567696[P].2004-07-29.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部